New Evernorth program to cap out-of-pocket costs for GLP-1s
May 21, 2025 · A 2023 analysis from J.P. Morgan estimates that the market for GLP-1s will exceed $100 billion by 2030. Cigna Evernorth Express Scripts GLP-1 Novo Nordisk Eli Lilly …
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly
May 22, 2025 · Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound, offering employers up to …
Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 ...
May 22, 2025 · Evernorth’s new program caps members’ costs at $200 per month and reduces GLP-1 prices for their plan sponsor. It also includes a simpler prior authorization process and …
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo …
May 23, 2025 · The GLP-1 drugs are currently only covered by half of The Cigna Group (NYSE:CI)'s clients. Customers who now provide coverage could save as much as 20%.
Cigna caps copays on GLP-1 drugs - LinkedIn
May 22, 2025 · Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per month, a sum that would count toward a …
Cigna’s Copay Caps Add to Growing Suite of Solutions to GLP-1 …
May 23, 2025 · In an effort to help employers meet the “growing demand” for weight loss medications, The Cigna Group’s Evernorth Health Services on May 21 announced a deal with …
Cigna, Novo Nordisk offer lower GLP-1 prices - endpoints.news
May 22, 2025 · Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers working with its pharmacy benefit manager. …
Cigna’s Evernorth caps weight-loss drug copays at $200/month
Cigna’s (NYSE: CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - …
Cigna’s Evernorth Secures New Deals to Lower Costs for Popular GLP-1 …
May 24, 2025 · Cigna’s pharmacy benefits unit Evernorth negotiates price reductions and improved access for GLP-1 weight loss drugs Wegovy and Zepbound, easing financial …
In the prescribing information for Zepbound, the recommended starting dose is 2.5 mg injected SC once weekly.9 The 2.5 mg dose is for treatment initiation and is not intended for chronic …
- Some results have been removed